DE60043782D1 - Immun-interaktive fragmente der alpha-c-untereinheit von inhibin - Google Patents
Immun-interaktive fragmente der alpha-c-untereinheit von inhibinInfo
- Publication number
- DE60043782D1 DE60043782D1 DE60043782T DE60043782T DE60043782D1 DE 60043782 D1 DE60043782 D1 DE 60043782D1 DE 60043782 T DE60043782 T DE 60043782T DE 60043782 T DE60043782 T DE 60043782T DE 60043782 D1 DE60043782 D1 DE 60043782D1
- Authority
- DE
- Germany
- Prior art keywords
- inhibin
- immune
- alpha
- sub
- unit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000893 inhibin Substances 0.000 title abstract 4
- ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 title abstract 4
- 239000012634 fragment Substances 0.000 title abstract 2
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 230000001594 aberrant effect Effects 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 230000002452 interceptive effect Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57449—Specifically defined cancers of ovaries
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
- Y10S436/813—Cancer
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/828—Cancer
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/85—Reproductive organs or embryos
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Endocrinology (AREA)
- Genetics & Genomics (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPQ3485A AUPQ348599A0 (en) | 1999-10-18 | 1999-10-18 | Novel peptides for development of diagnostic and therapeutic agents and methods of using same |
| AUPQ9162A AUPQ916200A0 (en) | 2000-08-03 | 2000-08-03 | Novel peptides for development of diagnostic and therapeutic agents and methods of using same |
| PCT/AU2000/001258 WO2001029079A1 (en) | 1999-10-18 | 2000-10-18 | IMMUNO-INTERACTIVE FRAGMENTS OF THE αC SUBUNIT OF INHIBIN |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE60043782D1 true DE60043782D1 (de) | 2010-03-18 |
Family
ID=25646178
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60043782T Expired - Lifetime DE60043782D1 (de) | 1999-10-18 | 2000-10-18 | Immun-interaktive fragmente der alpha-c-untereinheit von inhibin |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US7511123B2 (de) |
| EP (2) | EP1226166B1 (de) |
| AT (1) | ATE456575T1 (de) |
| CA (2) | CA2642066C (de) |
| DE (1) | DE60043782D1 (de) |
| DK (1) | DK1226166T3 (de) |
| NZ (1) | NZ518320A (de) |
| WO (1) | WO2001029079A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070031835A1 (en) * | 2003-03-28 | 2007-02-08 | Risbridger Gail P | Diagnosis of advanced cancer |
| WO2017223495A1 (en) * | 2016-06-24 | 2017-12-28 | University Of South Carolina | Inhibin as targetable regulators of angiogenesis |
| CN116375844B (zh) * | 2023-02-22 | 2024-03-29 | 四川农业大学 | 一种抑制素抗原肽及其疫苗和制备方法 |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4018653A (en) | 1971-10-29 | 1977-04-19 | U.S. Packaging Corporation | Instrument for the detection of Neisseria gonorrhoeae without culture |
| US4016043A (en) | 1975-09-04 | 1977-04-05 | Akzona Incorporated | Enzymatic immunological method for the determination of antigens and antibodies |
| US4843000A (en) | 1979-12-26 | 1989-06-27 | Syntex (U.S.A.) Inc. | Simultaneous calibration heterogeneous immunoassay |
| US4849338A (en) | 1982-07-16 | 1989-07-18 | Syntex (U.S.A.) Inc. | Simultaneous calibration heterogeneous immunoassay |
| US4366241A (en) | 1980-08-07 | 1982-12-28 | Syva Company | Concentrating zone method in heterogeneous immunoassays |
| US4424279A (en) | 1982-08-12 | 1984-01-03 | Quidel | Rapid plunger immunoassay method and apparatus |
| AU4437485A (en) | 1984-06-08 | 1986-01-10 | Biotechnology Australia Proprietary Limited | Inhibin isolated from ovarian follicular fluid |
| AU610821B2 (en) | 1985-04-18 | 1991-05-30 | Inhibin Pty Limited | Recombinant inhibin |
| US4737578A (en) * | 1986-02-10 | 1988-04-12 | The Salk Institute For Biological Studies | Human inhibin |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| WO1988005789A1 (en) | 1987-01-29 | 1988-08-11 | Biotechnology Australia Pty. Ltd. | Isolation of single chain proteins with fsh suppressing activity from follicular fluid |
| US5091513A (en) | 1987-05-21 | 1992-02-25 | Creative Biomolecules, Inc. | Biosynthetic antibody binding sites |
| US5785973A (en) | 1988-02-01 | 1998-07-28 | Praxis Biologics, Inc. | Synthetic peptides representing a T-cell epitope as a carrier molecule for conjugate vaccines |
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| US5433896A (en) | 1994-05-20 | 1995-07-18 | Molecular Probes, Inc. | Dibenzopyrrometheneboron difluoride dyes |
| US5227487A (en) | 1990-04-16 | 1993-07-13 | Molecular Probes, Inc. | Certain tricyclic and pentacyclic-hetero nitrogen rhodol dyes |
| US5723218A (en) | 1990-04-16 | 1998-03-03 | Molecular Probes, Inc. | Dipyrrometheneboron difluoride labeled flourescent microparticles |
| US5459276A (en) | 1994-05-20 | 1995-10-17 | Molecular Probes, Inc. | Benzazolylcoumarin-based ion indicators for heavy metals |
| US5648270A (en) | 1995-02-06 | 1997-07-15 | Molecular Probes, Inc. | Methods of sensing with fluorescent conjugates of metal-chelating nitrogen heterocycles |
| US5453517A (en) | 1992-02-25 | 1995-09-26 | Molecular Probes, Inc. | Reactive derivatives of bapta used to make ion-selective chelators |
| US5274113A (en) | 1991-11-01 | 1993-12-28 | Molecular Probes, Inc. | Long wavelength chemically reactive dipyrrometheneboron difluoride dyes and conjugates |
| US5326692B1 (en) | 1992-05-13 | 1996-04-30 | Molecular Probes Inc | Fluorescent microparticles with controllable enhanced stokes shift |
| US5405975A (en) | 1993-03-29 | 1995-04-11 | Molecular Probes, Inc. | Fluorescent ion-selective diaryldiaza crown ether conjugates |
| AU649066B2 (en) | 1990-07-25 | 1994-05-12 | Syngene, Inc. | Circular extension for generating multiple nucleic acid complements |
| CA2118806A1 (en) | 1991-09-18 | 1993-04-01 | William J. Dower | Method of synthesizing diverse collections of oligomers |
| EP0627932B1 (de) | 1992-11-04 | 2002-05-08 | City Of Hope | Antikörperkonstrukte |
| ATE187494T1 (de) | 1992-12-11 | 1999-12-15 | Dow Chemical Co | Multivalente einkettige antikörper |
| US5422252A (en) | 1993-06-04 | 1995-06-06 | Becton, Dickinson And Company | Simultaneous amplification of multiple targets |
| GB9410345D0 (en) * | 1994-05-24 | 1994-07-13 | Univ Oxford Brookes | Method of genetic testing |
| DK0862656T3 (da) | 1995-11-21 | 2001-04-09 | Univ Yale | Unimolekylær segmentamplifikation og -detektering |
| US5990085A (en) * | 1998-05-04 | 1999-11-23 | Michigan State University | Inhibin-HBc fusion protein |
-
2000
- 2000-10-18 NZ NZ518320A patent/NZ518320A/en not_active IP Right Cessation
- 2000-10-18 CA CA2642066A patent/CA2642066C/en not_active Expired - Fee Related
- 2000-10-18 DK DK00971123.5T patent/DK1226166T3/da active
- 2000-10-18 EP EP00971123A patent/EP1226166B1/de not_active Expired - Lifetime
- 2000-10-18 CA CA2387576A patent/CA2387576C/en not_active Expired - Fee Related
- 2000-10-18 WO PCT/AU2000/001258 patent/WO2001029079A1/en active IP Right Grant
- 2000-10-18 DE DE60043782T patent/DE60043782D1/de not_active Expired - Lifetime
- 2000-10-18 EP EP09004549A patent/EP2112159A3/de not_active Withdrawn
- 2000-10-18 AT AT00971123T patent/ATE456575T1/de not_active IP Right Cessation
-
2002
- 2002-04-18 US US10/125,187 patent/US7511123B2/en not_active Expired - Fee Related
-
2009
- 2009-03-30 US US12/414,180 patent/US8399202B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2642066C (en) | 2010-01-26 |
| CA2642066A1 (en) | 2001-04-26 |
| EP1226166B1 (de) | 2010-01-27 |
| WO2001029079A1 (en) | 2001-04-26 |
| NZ518320A (en) | 2003-10-31 |
| CA2387576A1 (en) | 2001-04-26 |
| EP1226166A1 (de) | 2002-07-31 |
| DK1226166T3 (da) | 2010-05-25 |
| US8399202B2 (en) | 2013-03-19 |
| EP2112159A3 (de) | 2010-04-21 |
| CA2387576C (en) | 2011-05-10 |
| US20030162229A1 (en) | 2003-08-28 |
| EP2112159A2 (de) | 2009-10-28 |
| ATE456575T1 (de) | 2010-02-15 |
| EP1226166A4 (de) | 2004-09-22 |
| US7511123B2 (en) | 2009-03-31 |
| US20090252735A1 (en) | 2009-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO985463D0 (no) | Forbindelser og fremgangsmÕter for behandling eller forhindring av sykdommer av kroppspassasjeveier | |
| DE69626660T2 (de) | 2-alkylpyrrolidine | |
| IS6170A (is) | Efni til öftrunar og meðferðar mýlildis | |
| BR9301667A (pt) | Processo de prevencao ou tratamento de doenca vascular hiperproliferativa em um mamifero,produto,aplicacao e composicao farmaceutica | |
| DE60236646D1 (de) | Anti-VEGF-2 Antikörper | |
| FR2709966B1 (fr) | Vaccin pour la prévention du syndrome respiratoire et de la reproduction du porc. | |
| CY1112229T1 (el) | Αντισωματα κατευθυνομενα εναντι οξειδωμενης απολιποπρωτεϊνης β | |
| DE69204639D1 (de) | Verwendung von Modafinil zur Herstellung eines antiischämischen Arzneimittels. | |
| DK0938326T3 (da) | Syntetiske phosphopeptider til behandling af knoglesygdomme | |
| NO965319D0 (no) | Rutil titandioksyd, og fremgangsmåte for fremstilling derav | |
| NO975234L (no) | Fremgangsmåte for behandling av maniske og bipolare forstyrrelser | |
| ATE240743T1 (de) | Verfahren und substanzen gegen protozoen | |
| ATE263187T1 (de) | Neuartige heparin bindende peptide | |
| PT845998E (pt) | Medicamentos para imunoterapia contendo anticorpos que reconhecem de forma especifica o antigenio mhcii de um paciente a ser tratado | |
| NO972967L (no) | Limblanding for glassfibre, dens anvendelse og de oppnådde produkter | |
| DE60043782D1 (de) | Immun-interaktive fragmente der alpha-c-untereinheit von inhibin | |
| NO980251D0 (no) | Behandling av konsentrasjonssvikt/hyperaktivitetsforstyrrelse | |
| FR2707994B1 (fr) | Composites moléculaires de siloxane, procédé de préparation desdits composites, et leurs utilisations. | |
| NO20012423D0 (no) | Antikonvulsjonsmiddelderivater som er nyttige ved behandling av posttraumatiske stresslidelser | |
| ITRM930502A0 (it) | Procedimento per la produzione di r amminocarnitina e s amminocarnitina. | |
| ES2061007T3 (es) | Preparacion farmaceutica que contiene proteina-s. | |
| DK1140119T3 (da) | Anvendelse af heparin med lav molekylvægt til forebyggelse og/eller behandling af motorneuronale sygdomme | |
| UA37249C2 (uk) | Спосіб інгібування стенозу та/або рестенозу (варіанти), спосіб інгібування рестенозу після проведення операції на коронарній артерії у людини (варіанти), спосіб зниження ймовірності виникнення чи запобігання негострих ішемічних ускладнень при ангіопластиці у людини | |
| ATE247467T1 (de) | Neue therapeutische verwendung von 1,6-dimethyl- 8beta-hydroxymethyl-10alpha-methoxyergolin | |
| NO910703D0 (no) | Fremgangsmaate for behandling av svovel-, jern- og sinkholdige metallurgiske biprodukter og/eller avfallsprodukter. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |